Introduction
============

Osteosarcoma (OS) develops most frequently in the extremities, and it is the most common histologic form of the primary bone cancers.[@JR160061-1] [@JR160061-2] Head and neck OSs are rare, comprising only 6 to 10% of all OSs.[@JR160061-3] [@JR160061-4] They typically present in the third or fourth decade of life and comprise only 1% of all pediatric head and neck malignancies. The most common craniofacial sites affected by OSs are the mandible and maxilla, followed by the calvaria and then the skull base.[@JR160061-4] [@JR160061-5] [@JR160061-6] On cytology, OS can be divided into several pathologic types, including the pleomorphic, epithelioid, chondroblastic, small cell, mixed, and osteoclast-like giant cell types.[@JR160061-6] In head and neck OSs, the chondroblastic type occurs most frequently.[@JR160061-7]

Skull base OSs can be challenging to resect and an aggressive surgical approach can result in poor cosmetic outcome.[@JR160061-8] Imaging plays a crucial role in the diagnosis of each subtype of OS and ultimately in patients\' survival because the diagnosis is based on a combination of histopathologic and imaging features. The therapeutic options and prognoses for different types of OS differ from each other, so correct diagnosis is essential.[@JR160061-9] [@JR160061-10] Magnetic resonance imaging (MRI) or computed tomographic (CT) scan should be used to assess the extent of the primary tumor.[@JR160061-11]

In this case report, we describe a pediatric patient of occipital OS of the chondroblastic type. The chondroblastic type of OS has an exceedingly poor outcome.[@JR160061-12] However, the detailed imaging description of such cases have not been reported in the previous literatures. We present the CT, MRI, and enhanced MRI features of this case, followed by a brief review of the related cases reported in the previous literatures

Case Report
===========

A 9-year-old boy was admitted to our hospital with a major complaint of a growing mass on his head. Physical examination found a firm and tough mass on the right occipital that showed no tenderness upon palpation. CT scan showed the right occipital bone to be irregularly thickened with fluffy and cloudy calcification, with a mass deriving from the internal occipital protuberance extending toward the basilar part of the occipital bone, invading the neighboring jugular foramen, the sublingual neural tube, and the mamillary process. On MRI, the lesion was 4.5- × 5.5- × 6.5-cm in size with calcifications areas of hypointensity in T1- and heterogeneous in T2-weighted series. Contrast MRI showed peripheral and septal enhancement in the interior side of the tumor ([Fig. 1](#FI160061-1){ref-type="fig"}). Significant mass effect was present, distorting the cerebellar hemisphere, pons, and the forth ventricle, which led to hydrocephalus, and the oppression of the sigmoid sinus and the transverse sinus. Histopathology examination reported lace-like osteoid material abutting the neoplastic cells ([Fig. 2](#FI160061-2){ref-type="fig"}), corresponding to the features of chondroblastic OS, and occipital bone chondroblastic OS was the final definitive diagnosis. A subtotal resection of the tumor was performed followed by radiation therapy. The patient died after half a year of local recurrence.

![(**A**) Computed tomography of the skull shows fluffy calcification. (**B**) T1-weighted image shows a 4- × 8- × 10-cm mass lesion, isointense to the skull. (**C, D**) The mass is hypointense in most areas in the T2-weighted series, with focal high signals in the T2-weighted series and reduced signal in FLAIR series.(**E**) In Gd-enhanced MRI, most areas show no enhancement or heterogeneous enhancement, with peripheral and atypical septal enhancement on the coronal plane (white arrows). (**F**) No hyperintensity was observed in both intra- and peritumoral areas in the DWI series.](10-1055-s-0037-1601876-i160061-1){#FI160061-1}

![Histopathologic examination (hematoxylin and eosin, ×200) shows lace-like osteoid material abutting the neoplastic cells.](10-1055-s-0037-1601876-i160061-2){#FI160061-2}

Discussion
==========

Craniofacial OSs are rare. They typically present in the third or fourth decade of life, account for fewer than 5% of OSs in children, and comprise only 1% of all pediatric head and neck malignancies. The most common craniofacial sites are the mandible and maxilla, followed by the calvaria and then the skull base.[@JR160061-13] [@JR160061-14] [@JR160061-15] Our case in the right occipital bone of skull base is a very rare location. A search of the English language literature revealed 22 cranial OSs previously reported in children ([Table 1](#TB160061-1){ref-type="table"}): 12 calvarial tumors and 10 tumors of the skull base. The mean age of the pediatric patients with cranial OS was 12.2 years old in this table. The patient in our case suffered at a younger age. On cytology, OS can be divided into pleomorphic, epithelioid, chondroblastic, small cell, mixed, and osteoclast-like giant cell types.[@JR160061-6] Our case is a chondroblastic subtype, which occurs most frequently in head and neck OSs.

###### Summary of previously reported cases of calvarial and skull base osteosarcomas in pediatric patients

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author and year              Age at diagnosis   Location                     Extent of resection   Adjuvant therapy      Follow-up   Outcome
  ---------------------------- ------------------ ---------------------------- --------------------- --------------------- ----------- -----------------------------
  Garland, 1945                17, M              Occipital                    NR                    RT                    NR          NR

  Reddy et al, 1973            8, F               Occipital                    Biopsy                RT                    NR          Dead, progressive disease

  Goodman and McMaster, 1976   15, F              Parietal-occipital           NR                    Chemotherapy and RT   6           Alive, disease free

  Wang et al, 1981             17, M              Frontal-parietal-occipital   NR                    RT                    6           Dead, progressive disease

  Benson et al, 1984           11, M              Frontal                      NR                    Chemotherapy          12          Alive, disease status

  Sundaresan et al, 1985       11, M\             Parietal\                    STR\                  Chemotherapy\         36\         Alive, progressive disease\
                               13, F              Skull base                   STR                   Chemotherapy          66          Alive, disease free

  Kornreich et al, 1988        12, F              Parietal                     NR                    Chemotherapy          144         Alive, disease free

  Mark et al, 1991             14, M              Anterior skull base          NR                    Chemotherapy and RT   12          Dead, progressive disease

  Shramek et al, 1992          8, M               Parietal-occipital           GTR                   Chemotherapy and RT   16          Alive, progressive disease

  Salvati et al., 1993         11, M              Frontal-temporal             STR                   RT                    9           Dead, progressive disease

  Chander et al, 2003          15, F              Frontal                      GTR                   NR                    NR          NR

  Author and Year              Age at diagnosis   Location                     Extent of resection   Adjuvant therapy      Follow-up   Outcome

  Ellison et al, 1996          11, F              Skull base                   STR                   Chemotherapy and RT   NR          NR

  Gadwal et al, 2001           9, M\              Sphenoid\                    NR\                   RT\                   9\          Dead, progressive disease\
                               1, M               Sphenoid                     NR                    NR                    NR          NR

  Chennupati et al, 2008       14, F              Skull base                   Biopsy                Chemotherapy and RT   12          Alive, progressive disease

  Kirby et al, 2011            16, M              Parietal                     GTR                   Chemotherapy          5           Alive, disease free

  Oakley et al, 2011           15, M              Anterior skull base          GTR                   Chemotherapy          NR          NR

  Ohno et al, 2011             14, F              Anterior skull base          STR                   Chemotherapy          26          Dead, progressive disease

  Meel et al, 2012             10, M              Sphenoid                     Biopsy                Chemotherapy and RT   18          alive, disease free

  Caroline et al, 2014         14, M\             Parietal skull base          GTR\                  Chemotherapy\         16\         Alive, disease free
                               12, M                                           GTR                   Chemotherapy          12          

  He et al, 2016               9, M               Occipital                    STR                   Chemotherapy and RT   6           Dead, progressive disease
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: GTR, gross total resection; NR, not reported; RT, radiation therapy; STR, subtotal resection.

The etiology of OS is unknown, but the major risk factors for development of OS in craniofacial bones may be similar to those of the long skeletal bones, consisting of exposure to radiation, retinoblastoma, Li-Fraumeni syndrome, and Paget\'s disease. The skull is a favored site for OS arising out of Paget\'s disease. Other bone abnormalities, such as fibrous dysplasia, multiple osteochondromatosis, chronic osteomyelitis, myositis ossificans, and trauma, have also been proposed as risk factors.[@JR160061-7] [@JR160061-15] [@JR160061-16] The presenting symptoms varied with the location of the tumors. The maxillary or cranial lesions usually produced no pain, which was in accordance with our case; however, mandibular tumors frequently presented with focal painful swelling.[@JR160061-17] [@JR160061-18] Other common presenting symptoms include headache, cranial nerve palsies, exophthalmos, and visual impairment due to different location of the tumor.[@JR160061-5] [@JR160061-13]

CT best demonstrates tumor mineralization, especially when minimal, and it is usually able to demonstrate tumor extension into the soft tissues. Hemorrhage, necrosis, and unmineralized, chondroblastic, or fibroblastic components of the tumor will appear as areas of low attenuation on CT if present. Unlike any other conventional OSs, we see fluffy calcification in our case, and we believe it is a characteristic of OS. The osteoblastic subtype is most common with nearly 90% containing variable amounts of cloudlike opacities.[@JR160061-19] Bose[@JR160061-20] reported an osteoblastic OS that appears as a large soft tissue density mass with a few bony densities. Compared with our case, the soft tissue mass is prominent and the calcification is less and diffuse.

MRI is the preferred modality for locally staging OS, and it should be performed before percutaneous biopsy because it can help identify areas of viable tumor and mineralized matrix. In our case of gadolinium (Gd)--enhanced MRI, we found no enhancement or heterogeneous enhancement in most areas of the tumor, with septonodular and rim enhancement, which is in in accordance with the current literature. Areas that demonstrate either a heterogeneous enhancement pattern or lack enhancement are the preferred sites for biopsy because they are more likely to contain both chondroid and osteoid elements that are necessary for the correct diagnosis.[@JR160061-21] [@JR160061-22] Chondrosarcomas shows similar image characteristic, but they occur in an older age with a mean age of 57 years old. DWI can also help identify chondroblastic OS. Chondroblastic OSs also have significantly higher minimum and maximum apparent diffusion coefficient (ADC) values compared with other conventional OS subtypes, but they have a lower minimum ADC and similar maximum ADC value compared with chondrosarcoma.[@JR160061-23]

Skull base OSs can be challenging to resect, and an aggressive surgical approach can result in poor cosmetic outcome. Thus, skull base tumors have a poorer prognosis than mandibular or maxillary tumors.[@JR160061-3] Complete surgical excision is the mainstay of treatment of the primary tumor. Local recurrence is the main reason of treatment failure and mortality in head and neck OSs. Positive margins and a high tumor grade correlate with a statistically significant decrease in survival.[@JR160061-11] In our case, the tumor could not be completely removed because it invades significant neighboring bone structures, including the jugular foreman and the sublingual neural tube. The patient died after 6 months as a result of local recurrence.

In summary, chondroblastic OS has been shown to be associated with a poor preoperative chemotherapy response and has a worse prognosis than other variants.[@JR160061-24] However, this subtype has some particular image characteristic, which helps surgeons identify before surgery and set early therapeutic regimens.
